Table 7 Details on patients who developed Symptomatic Radiation Pneumonitis and the Outlier with extreme DVH values who did not develop radiation pneumonitis
| Â | Age | Dose scheme | Synchronously treated lesions? | Largest tumor size | Date from SBRT to RP | Date from SBRT to death | Prior RT to lung? (months) | MLD | V20 |
|---|---|---|---|---|---|---|---|---|---|
Developed Symptomatic Radiation Pneumonitis | |||||||||
 Patient 1 | 75 | 60/8 | No | 3.3 cm | 3.3 mo | Alive | SBRT (20 mo) | 9.6 Gy | 10.3% |
 Patient 2 | 50 | 50/5 | Yes | 1.6 cm | 2.3 mo | Alive | CCRT (9 mo) | 7.3 Gy | 12.5% |
 Patient 3 | 80 | 50/5 | Yes | 3.6 cm | 7.4 mo | 8 mo | No | 8.2 Gy | 9.9% |
 Patient 4 | 68 | 50/5 | No | 4.0 cm | 0.8 mo | 2.7 mo | No | 7.4 Gy | 6.0% |
 Patient 5 | 60 | 50/5 | No | Liver | 5.6 mo | Alive | No | 6.7 Gy | 9.7% |
 Patient 6 | 80 | 60/6 | No | 2.8 cm | 5 mo | Alive | No | 4.7 Gy | 8.1% |
 Patient 7 | 71 | 50/5 | No | 1.7 cm | 1.2 mo | Alive | CCRT (3 mo) | 4.2 Gy | 4.7% |
 Patient 8 | 74 | 50/5 | No | 3.5 cm | 5.3 mo | Alive | No | 4.1 Gy | 5.5% |
Outlier who did not develop Symptomatic Radiation Pneumonitis | |||||||||
 Outlier 1 | 10 | 50/5 | Yes | 1.9 cm | n/a | Alive | No | 11.0 Gy | 18.4% |